Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Croda International ( (GB:CRDA) ) just unveiled an announcement.
Croda International reported that all resolutions at its one hundred and first Annual General Meeting were approved by shareholders via poll, covering the receipt of 2025 financial statements, a new directors’ remuneration policy and report, and the declaration of a final dividend of 63 pence per share. Investors also backed the election and re-election of board members, reappointment of KPMG as auditor, and authorities for share issuance, buybacks, and shorter notice for general meetings, reinforcing the board’s strategic flexibility and signalling continued shareholder support for the group’s capital allocation and governance framework.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £35.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International is a UK-based specialty chemicals group supplying high-value ingredients and technologies to markets such as personal care, life sciences, and performance technologies. The company focuses on innovative, sustainable chemistry solutions for global consumer and industrial customers.
Average Trading Volume: 575,812
Technical Sentiment Signal: Sell
Current Market Cap: £4.18B
For a thorough assessment of CRDA stock, go to TipRanks’ Stock Analysis page.

